| Drug Name | ||
| Eligible | Study sites | More information |
Anifrolumab (JASMINE) | ||
| Ages 18-75 with DM or PM | 185 sites worldwide | More details » AstraZeneca » 877-240-9479 NCT06455449 |
Brepocitinib (VALOR) | ||
| Adults with dermatomyositis (DM) | (currently not recruiting) | More details » Priovant 212-634-9743 NCT05437263 |
CABA-201 (CAR T cell therapy) | ||
| Ages 6-75 with DM, ASyS, NM | 11 locations in the US, 4 in UK, additional sites expected soon | More details » Cabaletta Bio » NCT06154252 |
CD-19-Targeted (CAR T cell therapy) | ||
| Adults with refractory DM, PM, NM | 54 sites in US and Europe | More details » Bristol Myers Squibb » 855-907-3286 NCT05869955 |
Daxdilimab | ||
| Adults with DM or ASyS | (currently not recruiting) | More details » Amgen 866-479-6742 NCT05669014 |
Dazukibart | ||
| Adults with active DM or PM | 126 sites worldwide | More details » Pfizer » 800-718-1021 NCT05895786 |
Efgartigimod (ALKIVIA) | ||
| Adults with IIM | 201 sites worldwide | More details » argenx 857-350-4834 NCT05523167 |
| Empasiprubart (Empacific) | ||
| Adults with DM | 14 sites in US 6 sites in Europe | More details » argenx 857-350-4834 NCT06284954 |
Enpatoran (NEPTUNIA) | ||
| Adults with DM or PM | 13 sites in US 18 sites abroad | More details » EMD Serono 888-275-7376 NCT05650567 |
| GLPG3667 (not yet named) | ||
| Adults with dermatomyositis (DM) | 59 sites worldwide | More details » Galapagos NV 321-534-2900 NCT05695950 |
| Nintedanib (MINT) | ||
| Adults with ILD and myositis | (currently not recruiting) | More details » MINTcc@pitt.edu 412-648-9989 NCT05799755 |
| Nipocalimab (SPIREA) | ||
| Adults with IIM | (currently not recruiting) | More details » J&J Innovative Medicine 844-434-4210 NCT05379634 |
NKX019 (allogeneic CAR NK cells targeting CD19) | ||
| Ages 18-65 with dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), or anti-synthetase syndrome (ASyS) | 20 sites in US 2 sites in AUS | More details » Nkarta, Inc. clinicaltrials@nkartatx.com NCT06733935 |
Rapcabtagene Autoleucel (CAR T cell therapy) | ||
| Adults with DM, NM, ASyS | 1 site in US 9 sites abroad | More details » Novartis 1-888-669-6682 NCT06665256 |
| RAY121 (RAINBOW Trial) | ||
| Ages 18-75 with dermatomyositis (DM) or immune-mediated necrotizing myopathy (IMNM) | 7 sites in US 5 sites in CAN ~70 sites abroad, additional sites expected late 2025 | More details » Chugai Pharmaceuticals Co., Ltd clinical-trials@chugai-pharm.co.jp NCT06371417 |
| Sirolimus | ||
| Adults with inclusion body myositis (IBM) | (currently not recruiting) | More details » 913-945-9926 NCT04789070 |
Ulviprubart (ABC008) | ||
| Adults with inclusion body myositis (IBM) | (currently not recruiting) | More details » Abcuro/Syneos 617-865-5079 NCT05721573 |